Theriva Biologics Stock Price on October 15, 2024
| TOVX Stock | USD 1.28 0.02 1.59% |
Below is the normalized historical share price chart for Theriva Biologics extending back to January 14, 2004. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Theriva Biologics stands at 1.28, as last reported on the 24th of November, with the highest price reaching 1.32 and the lowest price hitting 1.27 during the day.
If you're considering investing in Theriva Stock, it is important to understand the factors that can impact its price. Theriva Biologics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0457, which indicates the firm had a -0.0457% return per unit of risk over the last 3 months. Theriva Biologics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Theriva Biologics' Variance of 176.65, risk adjusted performance of (0.02), and Coefficient Of Variation of (2,328) to confirm the risk estimate we provide.
At this time, Theriva Biologics' Total Stockholder Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 58 M in 2024, whereas Common Stock is likely to drop slightly above 17.1 K in 2024. . Price To Sales Ratio is likely to drop to 241.35 in 2024. Price Earnings Ratio is likely to drop to -0.4 in 2024. Theriva Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 18th of December 2006 | 200 Day MA 6.6571 | 50 Day MA 1.8752 | Beta 1.338 |
Theriva |
Sharpe Ratio = -0.0457
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | TOVX |
Estimated Market Risk
| 13.34 actual daily | 96 96% of assets are less volatile |
Expected Return
| -0.61 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Theriva Biologics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Theriva Biologics by adding Theriva Biologics to a well-diversified portfolio.
Price Book 0.1446 | Book Value 53.888 | Enterprise Value -11.1 M | Enterprise Value Ebitda 1.7192 | Shares Float 658.8 K |
Related Headline
Biodexa Pharmaceticals Headline on 15th of October 2024
Biodexa Pharmaceuticals Stock Is Soaring After The Close Wha... by benzinga.com
Biodexa Pharmaceuticals shares are soaring in Tuesdays after-hours session after the company announced it was granted an extension to demonstrate compliance with Nasdaq listing requirements.
Theriva Biologics Valuation on October 15, 2024
It is possible to determine the worth of Theriva Biologics on a given historical date. On October 15, 2024 Theriva was worth 1.41 at the beginning of the trading date compared to the closed value of 1.39. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Theriva Biologics stock. Still, in general, we apply an absolute valuation method to find Theriva Biologics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Theriva Biologics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Theriva Biologics' related companies.
| Open | High | Low | Close | Volume | |
| 1.50 | 1.53 | 1.37 | 1.39 | 166,333 | |
10/15/2024 | 1.41 | 1.44 | 1.32 | 1.39 | 100,200 |
| 1.40 | 1.47 | 1.37 | 1.46 | 407,994 |
| Backtest Theriva Biologics | | | Theriva Biologics History | | | Theriva Biologics Valuation | Previous | Next |
Theriva Biologics Trading Date Momentum on October 15, 2024
| On October 16 2024 Theriva Biologics was traded for 1.46 at the closing time. The top price for the day was 1.47 and the lowest listed price was 1.37 . The trading volume for the day was 408 K. The trading history from October 16, 2024 was a factor to the next trading day price jump. The trading price change against the next closing price was 5.04% . The trading price change against the current closing price is 5.04% . |
Theriva Biologics Fundamentals Correlations and Trends
By evaluating Theriva Biologics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Theriva Biologics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Theriva financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Theriva Biologics Stock history
Theriva Biologics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Theriva is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Theriva Biologics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Theriva Biologics stock prices may prove useful in developing a viable investing in Theriva Biologics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 644.3 K | 1.1 M | |
| Net Loss | -22.6 M | -23.8 M |
Theriva Biologics Quarterly Net Working Capital |
|
Theriva Biologics Stock Technical Analysis
Theriva Biologics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Theriva Biologics Period Price Range
Low | November 24, 2024
| High |
0.00 | 0.00 |
Theriva Biologics cannot be verified against its exchange. Please verify the symbol is currently traded on NYSE MKT Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Theriva Biologics November 24, 2024 Market Strength
Market strength indicators help investors to evaluate how Theriva Biologics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Theriva Biologics shares will generate the highest return on investment. By undertsting and applying Theriva Biologics stock market strength indicators, traders can identify Theriva Biologics entry and exit signals to maximize returns
Theriva Biologics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Theriva Biologics' price direction in advance. Along with the technical and fundamental analysis of Theriva Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Theriva to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.77) | |||
| Total Risk Alpha | (2.67) | |||
| Treynor Ratio | (0.37) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Theriva Stock Analysis
When running Theriva Biologics' price analysis, check to measure Theriva Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theriva Biologics is operating at the current time. Most of Theriva Biologics' value examination focuses on studying past and present price action to predict the probability of Theriva Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theriva Biologics' price. Additionally, you may evaluate how the addition of Theriva Biologics to your portfolios can decrease your overall portfolio volatility.